AI assistant
RESMED INC — Director's Dealing 2015
May 29, 2015
30071_dirs_2015-05-29_350796bc-98d7-4f79-a0f3-cc84d0d293d7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2015-05-27
Reporting Person: Reiser Anne (President - ResMed EMEA-APAC)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-05-27 | ResMed Common Stock | M | 3000 | $17.30 | Acquired | 71120.212 | Direct |
| 2015-05-27 | ResMed Common Stock | S | 3000 | $57.907 | Disposed | 68334.869 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-05-27 | ResMed NQ Stock Options | $17.30 | M | 3000 | Disposed | 2015-11-24 | ResMed Common Stock (3000) | Direct |
Footnotes
F1: The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.
F2: This transaction was executed in multiple trades at prices ranging from $57.90 to $57.92. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.
F3: Includes 214.657 shares of ResMed stock purchased on April 30, 2015, through the Employee Stock Purchase Plan.